Investor Presentaiton slide image

Investor Presentaiton

MAX Healthcare Max Healthcare: Memorandum Profit & Loss Consolidation sheet of Network Financials for H1 FY22 MHIL & its subsidiaries & Silos Partner Healthcare Facilities ("PHF") Financials (IGAAP Unaudited)* (INR Cr) Eliminations & MHC Network (Consolidated) Ind AS Unaudited Balaji Society GM Modi Society Devki Devi Society IND AS Adjustment (2,6) (Certified by an ICA) Adjustment (1) Revenue from operations 2,019 275 173 369 (175) 2,660 Other Income (3) 19 1 1 5 (12) 15 Total Operating income 2,037 276 174 374 (186) 2,675 Purchase of pharmacy, drugs, consumables & implants 514 53 41 117 10 735 Employee benefits expense (4) 380 38 25 38 84 565 Other expenses (5) 608 116 80 136 (285) 653 Total Expenses 1,502 207 145 292 Operating EBITDA 536 69 69 29 82 22 (2) (191) 1,953 5 722 Less : non-operating expenses ESOP (Equity-settled Scheme) 25 Movement in fair value of contingent consideration payable and 10 amortisation of contract assets Exceptional costs: Provision for terminal benefits under VRS Reported EBITDA Finance Cost (Net) Depreciation & Amortisation Profit/ (Loss) before tax Tax expenses Profit/ (Loss) after tax 1 1 . 25 45 10 8 8 492 69 29 82 2 5 679 15 5 15 16 1 8 61 107 9 7 12 1 (15) 122 370 55 7 54 11 496 80 4 84 290 55 7 54 7 412 *Newly added PHF i.e. Vikrant Children Foundation has not been reflected separately due to negligible transactions in the entity's P&L (1) Mainly relates to Ind AS 116 (Accounting for Leases) at PHFs | (2) Eliminations relate to amount charged to PHFs under medical service agreements and sale of pharmaceuticals etc. Also includes impact on amortisation due to reversal of Intangible assets recognised in MHIL & its subsidiaries for contracts with PHFs. The NPV of the amount payable by a PHF to unconsolidated part of the other Society over the contract period has been accrued under IND AS and payment there against has thus been knocked off against the liability. | (3) Other Income includes income from Clinical trials, EPCG, Unclaimed Balances written back, Sponsorships and Contributions received, etc. | (4) Includes movement in OCI for actuarial valuation impact but excludes ESOP (Equity Settled) expenses. | (5) Net of reversal of prov. for bad debts and bad debts recovered in current period and also excludes movement in fair value of contingent consideration and amortisation of contract assets which is considered below Operating EBITDA | (6) Some of the items have been reclassified across line items to match with the commonly understood industry practices, e.g. forex gain/loss reclassified under Finance costs, Clinician costs reclassified under employee benefits expense, etc. 28
View entire presentation